NFKB1 and Alzheimer disease: Thus, the multi-dimensional effect of NAT on markers like NFκB, CREB, Tau, SP, AChE, TNF-α, and IL-6 could suggest its ability to ameliorate the neuroinflammation-induced cognitive decline in AD.